Canadian Stocks Fall 1.1%
Dow Jones2026/09/08 20:31This article was automatically generated by Dow Jones using technology from Automated Insights.
Stocks in Canada fell Tuesday, as the S&P/TSX Composite Index declined 1.1% to 36123.05.
Among large local companies, A.G.F. Management Cl B NV was the biggest laggard, plunging 9.3%, followed by shares of Shopify Cl A, which plunged 7.8%. Shares of Thomson Reuters tumbled 6.8%.
Ivanhoe Mines was the biggest leader during the session, surging 13%, and Marimaca Copper surged 13%. Ivanhoe Electric rounded out the top three movers, as shares surged 10%.
Stock indexes in the U.S. closed down with the Dow Jones Industrial Average dropping 1.2%. Meanwhile, the S&P 500 Index fell 0.6%, and the Nasdaq Composite Index dropped 0.3%.
On the currency front, the WSJ Dollar Index dropped 0.1% to 94.93. The Canadian dollar strengthened 0.2% against the U.S. dollar to US$0.73.
In the bond markets, the 10-year Canadian government bond yield rose 2.56 basis points to 3.804%.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 08, 2026 16:31 ET (20:31 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.